CoChat

Serum Levels of Dihomo-Gamma (γ)-Linolenic Acid (DGLA) Are Inversely Associated with Linoleic Acid and Total Death in Elderly Patients with a Recent Myocardial Infarction

Nilsen, Dennis Winston T., Myhre, Peder Langeland, Kalstad, Are, Schmidt, Erik Berg, Arnesen, Harald, Seljeflot, Ingebjørg · 2021 · Nutrients
Cited by 24

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Dihomo-gamma-linolenic acid (DGLA) is an n-6 polyunsaturated fatty acid (PUFA) derived from linoleic acid (LA). The LA:DGLA ratio reflects conversion from LA to DGLA. Low levels of DGLA in serum have been related to poor outcome in myocardial infarction (MI) patients. Aims: To assess the association of DGLA and LA:DGLA with total death as a primary aim and incident cardiovascular events as a secondary objective. Methods: Baseline samples from 1002 patients, aged 70 to 82 years, included 2–8 weeks after an MI and followed for 2 years, were used. Major adverse clinical events (MACE) consisted of nonfatal MI, unscheduled coronary revascularization, stroke, hospitalization for heart failure or all-cause death. Cox regression analysis was used to relate serum n-6 PUFA phospholipid levels (%wt) to the risk of MACE, adjusting for the following: (1) age, sex and body mass index (BMI); (2) adding baseline cod liver oil supplementation; (3) adding prevalent hypertension, chronic kidney disease and diabetes mellitus. Results: Median DGLA level in serum phospholipids was 2.89 (Q1–Q3 2.43–3.38) %wt. DGLA was inversely related to LA and LA:DGLA ratio. There were 208 incident cases of MACE and 55 deaths. In the multivariable analysis, the hazard ratio (HR) for the total death in the three higher quartiles (Q2–4) of DGLA as compared to Q1 was 0.54 (0.31–0.95), with p = 0.03 (Model-1), 0.50 (0.28–0.91), with p = 0.02 (Model-2), and 0.47 (0.26–0.84), with p = 0.012 (Model-3), and non-significant for MACE. Risk of MACE (Model 3) approached borderline significance for LA:DGLA in Q2–4 vs. Q1 [HR 1.42 (1.00–2.04), p = 0.052]. Conclusions: Low levels of DGLA were related to a high LA:DGLA ratio and risk of total death in elderly patients with recent MI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu13103475

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Illustration of the metabolic pathway of n-6 fatty acids.
Figure 1 Illustration of the metabolic pathway of n-6 fatty acids.CC BY · PubMed Central
Figure 2 Kaplan–Meier curves for baseline quartiles of DGLA and all-cause death (upper). Kaplan–Meier curves for baseline quartiles DGLA and risk of MACE (lower).
Figure 2 Kaplan–Meier curves for baseline quartiles of DGLA and all-cause death (upper). Kaplan–Meier curves for baseline quartiles DGLA and risk of MACE (lower).CC BY · PubMed Central
Figure 3 Kaplan–Meier curves for baseline LA:DGLA quartiles and all-cause death (upper). Kaplan–Meier curves for baseline LA:DGLA and risk of MACE (lower).
Figure 3 Kaplan–Meier curves for baseline LA:DGLA quartiles and all-cause death (upper). Kaplan–Meier curves for baseline LA:DGLA and risk of MACE (lower).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 22

  1. Marklund M. Wu J.H.Y. Imamura F. Del Gobbo L.C. Fretts A. de Goede J. Shi P. Tintle N. Wennberg M. Aslybekyan S. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Fatty Acids and Outcomes Research Consortium (FORCE). Meta-analysis. Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality Circulation 2019 139 2422 2436 10.1161/CIRCULATIONAHA.118.038908 30971107 PMC6582360 · DOI · Paper page
  2. Simopoulos A.P. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity Nutrients 2016 8 128 10.3390/nu8030128 26950145 PMC4808858 · DOI · Paper page
  3. Block R.C. Harris W.S. Reid R.J. Spertus J.A. Omega-6 and trans fatty acids in blood cell membranes: A risk factor for acute coronary syndromes? Am. Heart J. 2008 156 1117 1123 10.1016/j.ahj.2008.07.014 19033007 PMC2596644 · DOI
  4. Hussein N. Ah-Sing E. Wilkinson P. Leach C. Griffin B.A. Millward D.J. Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men J. Lipid. Res. 2005 46 269 280 10.1194/jlr.M400225-JLR200 15576848 · DOI · Paper page
  5. Knez M. Stangoulis J.C.R. Glibryic M. Tako E. The linolenic acid: Dihomo-γ-Linolenic Acid Ratio (LA:DGLA)—An Emerging Biomarker of Zn Status Nutrients 2017 9 825 10.3390/nu9080825 PMC5579618 28763004 · DOI
  6. Bolton-Smith C. Woodward M. Tavendale R. Evidence for age-related differences in the fatty acid composition of human adipose tissue, independent of diet Eur. J. Clin. Nutr. 1997 51 619 624 10.1038/sj.ejcn.1600455 9306089 · DOI
  7. Sergeant S. Rahbar E. Chilton F.H. Gamma-linolenic acid, dihomo-gamma linolenic, eicosanoids and inflammatory processes Eur. J. Pharm. 2016 785 77 86 10.1016/j.ejphar.2016.04.020 PMC4975646 27083549 · DOI · Paper page
  8. Wang X. Lin H. Gu Y. Multiple roles of dihomo-γ-linolenic acid against proliferation diseases Lipids Health Dis. 2012 11 25 10.1186/1476-511X-11-25 22333072 PMC3295719 · DOI · Paper page
  9. Fan Y.-Y. Chapkin R.S. Importance of dietary γ-linolenic acid in human health and nutrition J. Nutr. 1998 128 1411 1414 10.1093/jn/128.9.1411 9732298 · DOI · Paper page
  10. Kernoff P.B. Willis A.L. Stone K.J. Davies J.A. McNicol G.P. Antithrombotic potential of dihomo-gamma-linolenic acid in man Br. Med. J. 1977 2 1441 1444 10.1136/bmj.2.6100.1441 338112 PMC1632618 · DOI · Paper page
  11. Johnson M.M. Swan D.D. Surette M.E. Stegner J. Chilton T. Fonteh A.N. Chilton F.H. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans J. Nutr. 1997 127 1435 1444 10.1093/jn/127.8.1435 9237935 · DOI · Paper page
  12. Zurier R.B. Rosetti R.G. Jacobson E.W. DeMarco D.M. Liu N.Y. Temming J.E. White B.M. Laposata M. Gamma-linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial Arthritis Rheum. 1996 39 1808 1817 10.1002/art.1780391106 8912502 · DOI · Paper page
  13. Nilsen D.W.T. Aarsetoey H. Pönitz V. Brugger-Andersen T. Staines H. Harris W.S. Grundt H. The prognostic utility of dihomo-gamma-linolenic acid (DGLA) in patients with acute coronary heart disease Int. J. Cardiol. 2017 249 12 17 10.1016/j.ijcard.2017.09.202 28986060 · DOI
  14. Laake K. Myhre P. Nordby L.M. Seljeflot I. Abdelnoor M. Smith P. Tveit A. Arnesen H. Solheim S. Effects of ω3 supplementation in elderly patients with acute myocardial infarction: Design of a prospective randomized placebo controlled study BMC. Geriatr. 2014 14 74 10.1186/1471-2318-14-74 24928284 PMC4074832 · DOI · Paper page
  15. Folch J. Lees M. Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues J. Biol. Chem. 1957 226 497 509 10.1016/S0021-9258(18)64849-5 13428781 · DOI · Paper page
  16. Burdge G.C. Wright P. Jones A.E. Wootton S.A. A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction Br. J. Nutr. 2000 84 781 787 10.1017/S0007114500002154 11177194 · DOI · Paper page
  17. Ouchi S. Miyazaki T. Shimada K. Sugita Y. Shimizu M. Murata A. Kato T. Aikawa T. Suda S. Shiozawa T. Decreased circulating dihomo-gammalinolenic acid levels are associated with total mortality in patients with acute cardiovascular disease and acute decompensated heart failure Lipids Health Dis. 2017 14 16 10.1186/s12944-017-0542-2 PMC5556673 28806965 · DOI
  18. Al-Khudairy L. Hartley L. Clar C. Flowers N. Hooper L. Rees K. Omega 6 fatty acids for the primary prevention of cardiovascular disease Cochrane Database Syst. Rev. 2015 11 CD011094 10.1002/14651858.CD011094.pub2 26571451 · DOI · Paper page
  19. Harris W.S. Tintle N.L. Ramachandran V.S. Erythrocyte n-6 fatty acids and risk for cardiovascular outcomes and total mortality in the Framingham Heart Study Nutrients 2018 10 2012 10.3390/nu10122012 PMC6316092 30572606 · DOI
  20. Warensjø E. Sundstrøm J. Vessby B. Cederholm T. Riserius U. Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: A population-based prospective study Am. J. Clin. Nutr. 2008 88 203 209 10.1093/ajcn/88.1.203 18614742 · DOI · Paper page
  21. Vessby B. Gustafsson I.-B. Tengdal S. Boberg M. Andersson A. Desaturation and elongation of fatty acids and insulin action Ann. N. Y. Acad. Sci. 2002 967 183 195 10.1111/j.1749-6632.2002.tb04275.x 12079847 · DOI · Paper page
  22. Alsharari Z.D. Risérus U. Leander K. Sjøgren P. Carlsson A.C. Vikstrøm M. Laguzzi F. Gigante B. Cederholm T. De Faire U. Serum fatty acids, desaturase activities and abdominal obesity–A population-based study of 60-year old men and women PLoS ONE 2017 12 e0170684 10.1371/journal.pone.0170684 28125662 PMC5270324 · DOI

Metadata

Authors
Nilsen, D. W. T., Myhre, P. L., Kalstad, A., Schmidt, E. B., Arnesen, H., & Seljeflot, I.
Affiliations
  • Department of Cardiology, Stavanger University Hospital, 4068 Stavanger, Norway
  • Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0315 Oslo, Norway
  • Department of Cardiology, Aalborg University Hospital, 9000 Aalborg, Denmark
Venue
Nutrients
Publisher
MDPI AG
Published
2021-09-30
Volume
13
Issue
10
Pages
3475
ISSN
2072-6643
Cited by
24
References
7
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.